Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol ABL1 contributors: mct/shn - updated : 16-07-2016
HGNC name c-abl oncogene 1, receptor tyrosine kinase
HGNC id 76
ASSOCIATED DISORDERS
corresponding disease(s) BCR-ABL
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
tumoral        
in chronic myelogenous leukemia cells, silenced by promoter methylation
tumoral fusion translocation    
translocation t(22;9)(q11;q34)and fusion with NUP214 in T-cell acute lymphoblastic leukemia
tumoral fusion      
EML1-ABL1 fusion due to a cryptic t(9;14)(q34;q32), in T-cell acute lymphoblastic leukemia (ALL)
tumoral fusion      
fusion gene involving ABL1 and NUP214, in T-cell acute lymphoblastic leukemia (T-ALL)
tumoral fusion      
BCR-ABL1 and ETV6-ABL1 in T-cell acute lymphoblastic leukemia
tumoral fusion      
with SFPQ in t(1;9)(p34;q34) and B cell progenitor acute lymphoid leukemia
tumoral fusion      
fusion gene SNX2-ABL1 in a pediatric case of acute lymphoblastic leukemia (ALL), arising from a t(5;9)(q22;q34) translocation
Susceptibility
Variant & Polymorphism
Candidate gene
Marker
Therapy target
SystemTypeDisorderPubmed
cancerhemopathy 
ABL1 fusion proteins are sensitive to tyrosine kinase inhibitors, which can be included in future treatment strategy
neurologyneurodegenerativeParkinson/dementia Parkinsonism
inhibition of ABL1 may be a neuroprotective approach in the treatment of Parkinson disease
ANIMAL & CELL MODELS
  • mice homozygous for the c-abl mutation became runted and died 1 to 2 weeks after birth (
  • mice homozygous for the c-abl mutation are severely affected, displaying increased perinatal mortality, runtedness, and abnormal spleen, head, eye development, and major reductions in B cell progenitors (
  • Abl-/- mice are osteoporotic with long bones containing thinner cortical bone and reduced trabecular bone volume (
  • c-Abl deficiency result in a broad spectrum of defects in cell response to genotoxic stress, including activation of Chk1 and Chk2, activation of p53, nuclear foci formation, apoptosis, and DNA repair (